RALEIGH, N.C., Oct. 8 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will exhibit its comprehensive oncology study experience and expertise at the European Society for Medical Oncology’s 35th annual congress to be held 9-12 October 2010 in Milan, Italy.
Representatives from Medical Affairs, Operations and other departments will be available at booth 123 to discuss PRA’s approach to successful execution of oncology and hematology trials.
As a leader in oncology and hematology research, PRA has participated in more than 400 oncology, hematology, and supportive care trials globally in every phase and numerous indications since 2005. PRA’s well-established relationships with therapeutic experts, experienced investigative sites, and proficient project teams have led to a repeat business rate of 90% in oncology and hematology studies.
About PRA International
PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 3000 clinical trials through its 38 global offices.
PRA’s therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.
SOURCE PRA International
